Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 3447 Records) |
Query Trace: Prostate cancer[original query] |
---|
Toenail zinc and risk of prostate cancer in the MCC-Spain case-control study. Environmental research 2023 12 245 118065. Enrique Gutiérrez-González, Roberto Pastor-Barriuso, Adela Castelló, Gemma Castaño-Vinyals, Nerea Fernández de Larrea-Baz, Trinidad Dierssen-Sotos, José Juan Jiménez-Moleón, Ana Molina-Barceló, Guillermo Fernández-Tardón, Ángela Zumel-Marne, Víctor Moreno, José Luis Gómez-Ariza, M Ángeles Sierra, Tamara García-Barrera, Ana Espinosa, Elena Plans-Beriso, Inés Gómez-Acebo, Nuria Aragonés, Manolis Kogevinas, Marina Pollán, Beatriz Pérez-Góm |
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice. Japanese journal of clinical oncology 2023 12 . Shigekatsu Maekawa, Ryo Takata, Kie Sekiguchi, Masahiro Kagabu, Moe Toyoshima, Shinji Tamada, Kenta Takahashi, Daiki Ikarashi, Tomohiko Matsuura, Renpei Kato, Yoichiro Kato, Mitsugu Kanehira, Jun Sugimura, Takaya Abe, Tsukasa Baba, Wataru Oba |
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer. Frontiers in oncology 2024 4 14 1381134. Michael C Repka, Tamir Sholklapper, Alan L Zwart, Malika Danner, Marilyn Ayoob, Thomas Yung, Siyuan Lei, Brian T Collins, Deepak Kumar, Simeng Suy, Ryan A Hankins, Amar U Kishan, Sean P Colli |
Somatic Tumor Testing in Prostate Cancer: Experience of a Tertiary-Care Center Including Pathologist-Driven Reflex Testing of Localized Tumors at Diagnosis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2024 4 100489. Susan Prendeville, Harpreet Kaur, Shervin Ansari, Shifaa Alqaqa, Tracy L Stockley, Katherine Lajkosz, Theodorus van der Kwast, Carol C Cheung, Shamini Selvaraj |
Genomic ancestry and cancer among Latin Americans. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Alejandro Ruíz-Patiño, Leonardo Rojas, Jairo Zuluaga, Oscar Arrieta, Luis Corrales, Claudio Martín, Sandra Franco, Luis Raez, Christian Rolfo, Natalia Sánchez, Andrés Felipe Cardo |
Identification and validation of a novel anoikis-related prognostic model for prostate cancer. Molecular genetics & genomic medicine 2024 4 12 (4): e2419. Peipei Zhang, Wenzhi Lv, Yang Luan, Wei Cai, Xiangde Min, Zhaoyan Fe |
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to Lu-PSMA-617: A Retrospective Multicenter Cohort Study. JCO precision oncology 2024 4 8 e2300634. Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, Laura Graham, Roman Gulati, Colin C Pritchard, Michael C Haffner, Todd Yezefski, Jessica E Hawley, Heather H Cheng, Evan Y Yu, Petros Grivas, Robert B Montgomery, Peter S Nelson, Delphine L Chen, Thomas Hope, Amir Iravani, Michael T Schweiz |
Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases. Scientific reports 2024 4 14 (1): 9458. Magdalena Wójcik, Ulana Juhas, Elyas Mohammadi, Jonas Mattisson, Kinga Dr??ek-Chy?a, Edyta Rychlicka-Buniowska, Bo?ena Bruhn-Olszewska, Hanna Davies, Katarzyna Chojnowska, Pawe? Olszewski, Micha? Bie?kowski, Micha? Jankowski, Olga Rostkowska, Andrzej Hellmann, Rafa? P?ksa, Jacek Kowalski, Marek Zdrenka, Jarek Kobiela, Wojciech Zegarski, Wojciech Biernat, ?ukasz Szylberg, Piotr Remiszewski, Jakub Mieczkowski, Natalia Filipowicz, Jan P Dumans |
Exposure to environmental pollutants and genetic variants related to oxidative stress and xenobiotic metabolism-Association with prostate cancer. Environmental toxicology and pharmacology 2024 4 108 104455. Beatriz Álvarez-González, Antonio F Hernández, Alberto Zafra-Gómez, Lucia Chica-Redecillas, Sergio Cuenca-López, Fernando Vázquez-Alonso, Luis Javier Martínez-González, María Jesús Álvarez-Cube |
Collateral damage of NUDT15 deficiency in cancer provides a cancer pharmacogenetic therapeutic window with thiopurines. bioRxiv : the preprint server for biology 2024 4 . Jacob C Massey, Joseph Magagnoli, S Scott Sutton, Phillip J Buckhaults, Michael D Wya |
Combined SNPs sequencing and allele specific proteomics capture reveal functional causality underpinning the 2p25 prostate cancer susceptibility locus. Research square 2024 4 . Gong-Hong Wei, Dandan Dong, Peng Zhang, Mengqi Liu, Yu Wei, Zixian Wang, Wenjie Xu, Qixiang Zhang, Yao Zhu, Qin Zhang, Xiayun Yang, Jing Zhu, Liang Wa |
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate 2024 4 . Catherine H Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarak |
Exploration of vitamin D metabolic activity-related biological effects and corresponding therapeutic targets in prostate cancer. Nutrition & metabolism 2024 4 21 (1): 17. Lei Ding, Yong Wang, Zhentao Tang, Chenbo Ni, Qian Zhang, Qidi Zhai, Chao Liang, Jie |
The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities. Scientific reports 2024 4 14 (1): 7706. Ruotian Huang, M S Riana Bornman, Phillip D Stricker, Ilma Simoni Brum, Shingai B A Mutambirwa, Weerachai Jaratlerdsiri, Vanessa M Hay |
[Mendelian randomization of diabetes and prostate cancer risk in East Asian population]. Zhonghua nan ke xue = National journal of andrology 2024 4 29 (7): 596-601. Yue-Qi Wu, Xue-Fei Ding, Feng-Hong Cao, Yang Luan, Liang-Yong Zhu, Xiao Tan, Zhen-Hao |
Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer. The Journal of urology 2024 4 101097JU0000000000003927. Florian Rumpf, Anna Plym, Jane B Vaselkiv, Kathryn L Penney, Mark A Preston, Adam S Kibel, Lorelei A Mucci, Keyan Sala |
Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. The Prostate 2024 1 . Jason A White, Ernest T Kaninjing, Kayode A Adeniji, Paul Jibrin, John O Obafunwa, Chidiebere N Ogo, Faruk Mohammed, Ademola Popoola, Omolara A Fatiregun, Olabode P Oluwole, Roland J Thorpe, Balasubramanyam Karanam, Isra Elhussin, Stefan Ambs, Wei Tang, Melissa Davis, Paz Polak, Moray J Campbell, Kathryn R Brignole, Solomon O Rotimi, Windy Dean-Colomb, Folake T Odedina, Clayton Yat |
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations. Diagnostic pathology 2024 1 19 (1): 9. Anne Vogel, Anna Haupts, Michael Kloth, Wilfried Roth, Nils Hartma |
ER-positive and BRCA2-mutated breast cancer: a literature review. European journal of medical research 2024 1 29 (1): 30. Pu-Chun Li, Yi-Fan Zhu, Wen-Ming Cao, Bei |
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients. European urology oncology 2024 1 . Olivier Cussenot, Kirsten M Timms, Emmanuel Perrot, Pascal Blanchet, Laurent Brureau, Cara Solimeno, Gaelle Fromont, Eva Comperat, Geraldine Cancel-Tass |
Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World journal of clinical cases 2024 1 12 (1): 32-41. Zhen Song, Qi Zhou, Jiang-Lei Zhang, Jun Ouyang, Zhi-Yu Zha |
Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer. Experimental & molecular medicine 2024 1 . Jeesoo Chae, Seung-Hyun Jung, Eun Ji Choi, Jae Woong Kim, Na Yung Kim, Sung Won Moon, Ji Youl Lee, Yeun-Jun Chung, Sug Hyung L |
Integrated analysis identifies GABRB3 as a biomarker in prostate cancer. BMC medical genomics 2024 1 17 (1): 41. Jun-Yan Chen, Chi-Fen Chang, Shu-Pin Huang, Chao-Yuan Huang, Chia-Cheng Yu, Victor C Lin, Jiun-Hung Geng, Chia-Yang Li, Te-Ling Lu, Bo-Ying B |
PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing Evidence. Clinical genitourinary cancer 2024 1 . Francesco Ditonno, Alberto Bianchi, Sarah Malandra, Antonio Benito Porcaro, Emanuela Fantinel, Riccardo Negrelli, Matteo Ferro, Michele Milella, Matteo Brunelli, Riccardo Autorino, Maria Angela Cerruto, Alessandro Veccia, Alessandro Antonel |
Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway. Human pathology 2024 1 . Jon Mahlow, Marc Barry, Daniel J Albertson, Yeon Jung Jo, Michael Balatico, Tori Seasor, Georges Gebrael, Shruti A Kumar, Nicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, Umang Swami, Deepika Siro |
Risk of clinically significant prostate cancer after a non-suspicious prostate MRI - a comparison with the general population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2024 1 . Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas Mirtti, Antti Rannik |
PTEN, ERG, SPINK1, and TFF3 Status and Relationship in a Prostate Cancer Cohort from Jordanian Arab Population. Medicina (Kaunas, Lithuania) 2024 1 60 (1): . Samir Al Bashir, Mohammed S Alorjani, Khalid Kheirallah, Mohammad Al Hamad, Husam K Haddad, Ahmad Al-Dwairy, Baha A Bani-Fawwaz, Najla Aldaoud, Omar Halalsheh, Saddam Amawi, Ismail I Matal |
Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer. Medicina (Kaunas, Lithuania) 2024 1 60 (1): . Tomas Januskevicius, Ieva Vaicekauskaite, Rasa Sabaliauskaite, Augustinas Matulevicius, Alvydas Vezelis, Albertas Ulys, Sonata Jarmalaite, Feliksas Jankevici |
Possible prognostic impact of PKC? genetic variants in prostate cancer. Cancer cell international 2024 1 24 (1): 24. Amna Hafeez, Maria Shabbir, Khushbukhat Khan, Janeen H Trembley, Yasmin Badshah, Sameen Zafar, Kanza Shahid, Hania Shah, Naeem Mahmood Ashraf, Arslan Hamid, Tayyaba Afsar, Ali Almajwal, Afifa Marium, Suhail Raz |
Checkpoint Kinase 2 (CHEK2) Gene Mutation in a Patient With Breast and Prostate Cancer: A Unique Presentation of a Rare Disease. Cureus 2024 1 15 (11): e49710. Samar N Ekram, Nasser Al Shanbari, Bassam M Bin Laswad, Abdulrahman Alharthi, Waseem Tayeb, Abdulbari Bah |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: